According to Pan et al., the concentration of circulating fetuin-A in MetS patients was significantly higher than in control groups, with a slight tendency for the risk of MetS to increase with an increase in the concentration of circulating fetuin-A [62]. Here, AHSG is linked to metabolic syndrome.